Critical appraisal of the adequacy of surgical indications for non-functioning pancreatic neuroendocrine tumours.

Potential overtreatment occurs in nearly one-third of patients undergoing surgery for non-functioning pancreatic neuroendocrine tumours. Tumour diameter emerges as the sole variable capable of predicting the risk of both potential surgical overtreatment and undertreatment.